Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
108 studies found for:    mdv3100 | Open Studies
Show Display Options
Rank Status Study
1 Not yet recruiting Fulvestrant Plus Enzalutamide in ER+/Her2- Advanced Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Fulvestrant with Enzalutamide
2 Recruiting A Positron Emission Tomography/Computed Tomography (PET/CT) Bone Imaging Study in Patients Receiving Enzalutamide for Castration-Resistant Prostate Cancer (CRPC)
Conditions: Prostate Carcinoma Metastatic to the Bone;   Castration Resistant Prostate Cancer
Intervention: Drug: Enzalutamide
3 Recruiting Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer
Conditions: Nonmetastatic Castration-Resistant Prostate Cancer;   Prostate Cancer;   Cancer of the Prostate
Interventions: Drug: Enzalutamide;   Drug: Placebo
4 Recruiting Multicentre Biomarker Study in CRPC Treated With Enzalutamide
Conditions: Prostate Cancer;   Castration Resistant;   Enzalutamide
Intervention: Drug: Enzalutamide
5 Recruiting Efficacy and Safety Study of Enzalutamide in Combination With Paclitaxel Chemotherapy or as Monotherapy Versus Placebo With Paclitaxel in Patients With Advanced, Diagnostic-Positive, Triple-Negative Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Enzalutamide;   Drug: Placebo;   Drug: Paclitaxel
6 Recruiting Enzalutamide in Combination With Carboplatin and Paclitaxel in Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Drug: Enzalutamide;   Drug: Carboplatin;   Drug: Paclitaxel
7 Recruiting Enzalutamide + External Beam Rt For Prostate
Condition: Intermediate Risk Prostate Cancer
Interventions: Drug: Enzalutamide;   Radiation: External Beam Radiation
8 Recruiting Enzalutamide for Bladder Cancer Chemoprevention
Condition: Bladder Cancer
Intervention: Drug: Enzalutamide
9 Recruiting Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)
Conditions: Hormone Sensitive Prostate Cancer;   Prostate Cancer;   Cancer of the Prostate
Interventions: Drug: Enzalutamide;   Drug: Placebo;   Drug: Leuprolide
10 Recruiting Randomized Salvage Radiation Therapy Plus Enzalutamide Post Prostatectomy
Condition: Adenocarcinoma of the Prostate
Interventions: Drug: Enzalutamide;   Radiation: SRT
11 Recruiting A Study to Assess the Efficacy and Safety of Enzalutamide in Subjects With Advanced Hepatocellular Carcinoma
Condition: Advanced Hepatocellular Carcinoma
Interventions: Drug: enzalutamide;   Drug: placebo
12 Recruiting A Study of ZEN003694 in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer
Condition: Metastatic Castration-Resistant Prostate Cancer
Interventions: Drug: ZEN003694;   Drug: Enzalutamide
13 Not yet recruiting Study on Enzalutamide and Flutamide in Patients With Castration Resistant Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Enzalutamide;   Drug: Flutamide;   Other: Androgen deprivation therapy
14 Recruiting A Study of Enzalutamide Re-treatment in Metastatic Castration-resistant Prostate Cancer After Docetaxel and/or Cabazitaxel Treatment
Condition: Metastatic Castration Resistant Prostate Cancer
Intervention: Drug: Enzalutamide
15 Recruiting European Observational Study of Enzalutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)
Condition: Metastatic Castration Resistant Prostate Cancer
Intervention: Drug: enzalutamide
16 Recruiting Enzalutamide and Hormone Therapy Before, During, and After Radiation for High Risk Localized Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Enzalutamide;   Drug: Leuprolide acetate;   Radiation: radiation
17 Recruiting A Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)
Condition: Metastatic Hormone Sensitive Prostate Cancer
Interventions: Drug: Enzalutamide;   Drug: Placebo
18 Not yet recruiting Preoperative Fulvestrant With or Without Enzalutamide in ER+/Her2- Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Enzalutamide;   Drug: Fulvestrant
19 Recruiting Enzalutamide in Patients With Androgen Receptor Positive (AR+) Ovarian, Primary Peritoneal or Fallopian Tube Cancer and One, Two or Three Prior Therapies
Conditions: Advanced Epithelial Ovarian;   Recurrent Epithelial Ovarian;   Fallopian Tube;   Primary Peritoneal Carcinoma
Intervention: Drug: Enzalutamide
20 Recruiting Long-Term Specified Drug Use-Results Survey for Xtandi Capsule
Condition: Castration-resistant Prostate Cancer
Intervention: Drug: Xtandi

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.